| http://www.w3.org/ns/prov#value | - For over four decades, flow cytometry has supported drug discovery and development, including the development of the first humanized monoclonal antibody therapy alemtuzumab (Campath) for the treatment of B-cell chronic lymphocytic leukemia.1 The technology has become progressively more sensitive and is now routinely used for more in-depth quantitative analyses.
|
